Enara Bio raised $32.5m in Series B funding co-led by Pfizer Ventures and M Ventures, joined by RA Capital, Samsara BioCapital, and SV Health Investors.
03 September 2024
03 September 2024
Total investments received (USD): 50M
Round value (USD): 32.5M
Company: Enara Bio
Related deals
Mestag Therapeutics raised $40 million in a round led by investors including SV Health Investors, Johnson & Johnson Innovation and Forbion.
Investments
02 March 2026
Engitix raised $25m in a Series A extension from Netherton Investments
Investments
09 December 2025
Cellular Origins raises a $40 million Series A round led by Johnson & Johnson, joined by Highland Europe, BGF, NYBC Ventures, and TTP Group
Investments
04 December 2025
Relation Tx raised $26m from insiders NVentures, DCVC, and Magnetic Ventures.
Investments
02 December 2025
EpilepsyGTx raised $33m in Series A funding from XGEN Venture and the British Business Bank.
Investments
02 December 2025
Belgium
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Portugal
Spain